期刊文献+

RNA干扰表皮生长因子受体在皮肤鳞状细胞癌治疗中的研究进展

Study of Treatment with RNAi Targeted Epidermal Growth Factor Receptor for Cutaneous Squamous Cell Carcinoma
暂未订购
导出
摘要 RNA干扰(RNAi)是利用同源性双链RNA诱发序列特异的转录后基因沉默现象,是研究基因功能的重要工具。表皮生长因子受体在皮肤鳞状细胞癌中过度表达,且EGFR信号通路的启动后可促进细胞增殖、转移、血管生成及阻断细胞凋亡,因此被作为开发肿瘤治疗方法的新靶点。现将对RNA干扰表皮生长因子受体在皮肤鳞状细胞癌中的治疗作用予以综述。 RNA interference(RNAi)is a phenomenon of post-transcriptional genes silencing induced by sequence-specific double-stranded RNA(dsRNA).RNAi has become an important tool in the filed of gene therapy.EGFR is over-expressed in cutaneous squamous cell carcinoma,triggering a cascade of downstream signals if activated and resulting in an increase of cellular proliferation,metastasis angiogenesis and blockade of cells apoptosis,which has been developed as a new target for tumor therapy.In this review,we focus on the potential therapeutic use of EGFR targeted RNAi on cutaneous squamous cell carcinoma.
出处 《医学综述》 2010年第10期1482-1484,共3页 Medical Recapitulate
基金 江苏省教育厅2008年度省属高校自然科学基础研究面上项目(08KJD320009)
关键词 表皮生长因子受体 小干扰RNA 皮肤鳞癌 Epidermal growth factor receptor RNA interference Cutaneous squamous cell carcinoma
  • 相关文献

参考文献3

二级参考文献20

  • 1Wakeling AE.Epidermal growth factor receptor tyrosine kinase inhibitors.Curr Opin Pharmacol,2002,2:382-387.
  • 2Elbashir SM,Lendeckel W,Tuschl T.RNA interference is mediated by 21-and 22-nucleotide RNAs.Genes Dev,2001,15:188-200.
  • 3Nagy P,Arndt-Jovin DJ,Jovin TM.Small interfering RNAs suppress the expression of endogenous and GFP-fused epidermal growth factor receptor (erbB1) and induce apoptosis in erbB1-overexpressing cells.Exp Cell Res,2003,285:39-49.
  • 4Magne N,Fischel JL,Dubreuil A,et al.Sequence-dependent effects of ZD1839 ('Iressa') in combination with cytotoxic treatment in human head and neck cancer.Br J Cancer,2002,86:819-827.
  • 5Huang SM,Li J,Armstrong EA,et al.Modulation of radiation response and tumor-induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 (Iressa).Cancer Res,2002,62:4300-4306.
  • 6Hirata A,Ogawa S,Kometani T,et al.ZD1839 (Iressa) induces antiangiogenic effects through inhibition of epidermal growth factor receptor tyrosine kinase.Cancer Res,2002,62:2554-2560.
  • 7Tsai CM,Chang KT,Li L,et al.Interrelationships between cellular nucleotide excision repair,cisplatin cytotoxicity,HER-2/neu gene expression,and epidermal growth factor receptor level in non-small cell lung cancer cells.Jpn J Cancer Res,2000,91:213-222.
  • 8Wakeling AE. Epidermal growth factor receptor tyrosine kinase inhibitors. Curr Opin Pharm 2002; 2: 382-7.
  • 9Wakeling AE, Guy SP, Woodbum JR, Ashton SE, Curry BJ,Barker AJ, et al. ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy. Cancer Res 2002; 62: 5749-64.
  • 10Elbashir SM, Harborth J, Lendechel W, Yalcin A, Weber K,Tuschl T. Duplexes of 21-nucleotides RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411:494-8.

共引文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部